43.72 MXN
10.37 B MXN
75.17 B MXN
About Hologic, Inc.
Sector
Industry
CEO
José E. Almeida
Website
Headquarters
Marlborough
Founded
1985
IPO date
Mar 1, 1990
Identifiers
3
ISIN US4364401012
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focus on women’s health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of HOLX is 1,290.48 MXN — it has increased by 20.74% in the past 24 hours. Watch Hologic, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange Hologic, Inc. stocks are traded under the ticker HOLX.
HOLX stock is 17.45% volatile and has beta coefficient of 0.09. Track Hologic, Inc. stock price on the chart and check out the list of the most volatile stocks — is Hologic, Inc. there?
Yes, you can track Hologic, Inc. financials in yearly and quarterly reports right on TradingView.
HOLX earnings for the last quarter are 18.75 MXN per share, whereas the estimation was 19.75 MXN resulting in a −5.08% surprise. The estimated earnings for the next quarter are 18.83 MXN per share. See more details about Hologic, Inc. earnings.
Hologic, Inc. revenue for the last quarter amounts to 18.89 B MXN, despite the estimated figure of 19.32 B MXN. In the next quarter, revenue is expected to reach 18.52 B MXN.
HOLX net income for the last quarter is 3.23 B MXN, while the quarter before that showed 3.43 B MXN of net income which accounts for 0.00% change. Track more Hologic, Inc. financial stats to get the full picture.
No, HOLX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 5, 2026, the company has 7.07 K employees. See our rating of the largest employees — is Hologic, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hologic, Inc. EBITDA is 22.75 B MXN, and current EBITDA margin is 30.94%. See more stats in Hologic, Inc. financial statements.
Like other stocks, HOLX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hologic, Inc. stock right from TradingView charts — choose your broker and connect to your account.